Skip to main content
 -
  • About
    • Contact Us
    • Editorial Board
    • Mission
    • History
    • Media
    • Permissions
  • The Journal
    • By Author
    • Past Issues
    • BC Doctors
      • Obituaries
      • Interviews
      • Proust for Physicians
      • The Good Doctor
    • Opinions
      • Back Page
      • BC Stories
      • Blog
      • Editorials
      • Letters to the Editor
      • Premise
      • President's Comment
    • Columns
      • BC Centre for Disease Control
      • Billing Tips
      • Council on Health Promotion
      • College Library
      • Family Practice Services Committee
      • Joint Collaborative Committees
      • News
      • Shared Care Committee
      • Specialist Services Committee
      • WorkSafeBC
    • Articles
      • Clinical Articles
      • MDs To Be
      • Special Features
      • COVID-19
      • Early Online
  • Classifieds
  • CME Calendar
  • Submit Content
    • Article
    • Letter to the Editor
    • Theme Issue
    • Proust Questionnaire
    • Blog Post
    • For an Award
  • Advertise
    • Place Display Ad
    • Place Classified Ad
    • Place CME Calendar Ad
    • Cancel your Classified or CME ad
    • Shopping cart
  • none
 -

Author profile

Janet Webb, BSc(Pharm), MSc,

hide first letter

BC Centre for Disease Control / January/February 2007

Venlafaxine: Troubling toxicity in overdose

Venlafaxine (Effexor), a serotonin and norepinephrine reuptake inhibitor, entered the Canadian market in 1994. As with any new medication, experience with overdose was extremely limited when venlafaxine was introduced.... Read More

BCMJ

DOBC

 

ISSN 0007-0556 (Print)
ISSN 2293-6106 (Online)

Established 1959